Skip to content
Most popular
-
Read more
MDFA showcases groundbreaking research projects in new impact report
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
-
Read more
Could a new supplement help slow AMD?
A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).
Read moreResearch study measuring the impact of AMD on quality of life
If you have AMD, you could help this MDFA-funded study.
Read morePotential treatment for atrophic AMD on the horizon
Results have now been presented at medical conferences in the USA.
Read morePotential new treatment for dry AMD
Apellis announces initial results from two phase III studies in geographic atrophy.
Read moreWellbeing and AMD
MDFA funded researcher Ms Diana Tang is rolling out the Movement, Interaction and Nutrition for Greater Lifestyles in the Elderly – or MINGLE – program.
Read moreCreating the perfect laboratory macula model
MDFA funded researcher, Dr Anai Gonzalez Cordero is creating an organoid – essentially a mini organ in a dish – with a macular structure.
Read moreMDFA awards $1 million to eight exciting research projects
MDFA has awarded more than $1 million in research funding to eight promising projects, in the search for a cure for macular diseases.
Read more10 years of MDFA Research Grants
Celebrating the 10th anniversary of MDFA’s Research Grants Program, this free publication introduces you to the talented researchers your donations have funded since 2011.
Read moreGrant Family Fund bequest: Lasting legacy to ‘best mates’
Faye Grant included MDFA in her Will. Her bequest is now funding vital, innovative research into macular disease through the Grant Family Fund.
Read moreScientists test potential drug developed in Australia
A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.
Most recent
MDFA showcases groundbreaking research projects in new impact report
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
Macular Disease Foundation Australia welcomes Federal Government cost increase freeze on PBS medicines
Affording sight-saving treatments and support is a challenge faced by many people in the macular disease community.
MDFA’s first South Australian Peer Support group to launch in April
Connecting with other people who are going through similar health experiences can improve how you manage your own condition.
Social Impact Survey 2: What did your patients tell us?
Macular Disease Foundation Australia (MDFA) is committed to understanding the impact of macular disease on the lives and health of people who live with the condition. One of the ways we do this is through our Social Impact research.
Diabetic eye disease: Laying the foundations for new treatments
Professor Chandra Balaratnasingam’s MDFA-funded research is exploring the cellular changes that occur in diabetic macular ischaemia (DMI) to help develop a breakthrough therapy.
Improving the diagnosis of macular disease
Grant Family Fund support is allowing Dr Alexis Ceecee Britten-Jones to research a way to ensure people with rare inherited macular dystrophies receive the right treatment for them in future.
AI, NASA and dry AMD
Find out how the Grant Family Fund is helping Dr Xavier Hadoux use cutting-edge technology to detect the early signs of macular disease.
Could a new supplement help slow AMD?
A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).
2023 Research Grant Program recipients announced
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.